Will infrastructure be the centrepiece by which governments stimulate their economies?
Listen to Co-Founder and Senior Portfolio Manager Nick Langley discuss:
(40 minute listening time)
Drug development appears to be stabilizing, as improving biopharma funding and healthier demand create a more constructive backdrop for contract research organizations and life science tools companies.
Read full article